EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biofabrication of Endothelialized, Intrinsically Vascularized 3D‐Printed Recombinant Spider Silk Scaffolds

Claire M Weinhold, Stefanie Heltmann-Meyer iD, Xuen J Ng iD, Thomas Scheibel iD, Tobias Fey iD, Harald Wajant iD, Carol Geppert iD, Andreas Arkudas iD, Dominik Steiner iD, Raymund E Horch iD

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202504883 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Claire M Weinhold und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Printing, Three-Dimensional, Tissue Scaffolds, Silk. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tissue engineering aims to create functional tissues for regenerative medicine, where scaffold design and vascular integration remain key challenges. Therefore, the capability to promote vascularization, long‐term stability and biocompatibility are important requirements to a scaffold material. One goal is to optimize the cell‐to‐scaffold material interaction to support vascularization and de novo tissue formation. This study evaluates 3D‐printed and non‐printed recombinant spider silk protein eADF4(C16)‐RGD hydrogels in a rat arteriovenous (AV) loop model. The hydrogels were implanted subcutaneously using polytetrafluorethylene (PTFE) chambers, where the lower half contained an acellular 3D‐printed spider silk hydrogel, while the upper half either contained a manually extruded eADF4(C16)‐RGD hydrogel without cells (group A) or with T17b endothelial progenitor (EPCs) cells embedded (group B). Constructs were explanted after 2, 4, and 12 weeks. The 3D‐printed eADF4(C16)‐RGD scaffolds showed good biocompatibility and vascularization. Interestingly, the presence of T17b cells resulted in an increased biodegradation, with the 12 week constructs nearly completely dissolved. The cell‐laden constructs showed a significantly increased vascular density per construct area after 4 weeks compared to the cell‐free constructs. This study demonstrates that both the scaffold ultrastructure and the integration of T17b cells are effective strategies to enhance the functionality of biomaterials for tissue engineering.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Printing, Three-DimensionalTissue ScaffoldsSilkAnimalsRatsSpidersTissue EngineeringHydrogelsRecombinant ProteinsNeovascularization, PhysiologicEndothelial Progenitor CellsBiocompatible MaterialsMaleAngiogenesisOligopeptides

Stichwörter der Autor:innen

T17b EPCsbiofabricationbioprintinghydrogelspider silktissue engineering

Substanzen

SilkHydrogelsRecombinant Proteinsarginyl-glycyl-aspartic acidBiocompatible MaterialsOligopeptides

Autor:innen und Institutionen

  • Department of Plastic and Hand Surgery, University Hospital of Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • University Center for Orthopedics, Trauma and Plastic Surgery, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
  • Department of Biomaterials, University of Bayreuth, Bayreuth, Germany.
  • Department of Materials Science and Engineering, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.

ORCID-Profile: Stefanie Heltmann-Meyer, Xuen J Ng, Thomas Scheibel, Tobias Fey, Harald Wajant, Carol Geppert, Andreas Arkudas, Dominik Steiner, Raymund E Horch

Förderung

  • the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

Zitieren

APA

Weinhold, C. M., Heltmann-Meyer, S., Ng, X. J., Scheibel, T., Fey, T., Wajant, H., Geppert, C., Arkudas, A., Steiner, D., & Horch, R. E. (2026). Biofabrication of Endothelialized, Intrinsically Vascularized 3D‐Printed Recombinant Spider Silk Scaffolds. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504883

Vancouver

Weinhold CM, Heltmann-Meyer S, Ng XJ, Scheibel T, Fey T, Wajant H, et al. Biofabrication of Endothelialized, Intrinsically Vascularized 3D‐Printed Recombinant Spider Silk Scaffolds. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504883

BibTeX
@article{Weinhold2026,
  author = {Weinhold, Claire M and Heltmann-Meyer, Stefanie and Ng, Xuen J and Scheibel, Thomas and Fey, Tobias and Wajant, Harald and Geppert, Carol and Arkudas, Andreas and Steiner, Dominik and Horch, Raymund E},
  title = {Biofabrication of Endothelialized, Intrinsically Vascularized 3D‐Printed Recombinant Spider Silk Scaffolds},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202504883}
}
Kostenlos starten →